Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
BMC Res Notes ; 13(1): 348, 2020 Jul 22.
Article de Anglais | MEDLINE | ID: mdl-32698844

RÉSUMÉ

OBJECTIVE: The aim of the study was to determine the level of insecticide resistance and diversity in Anopheles mosquitoes in northern Uganda. Standard WHO insecticide susceptibility test assays were used to test for susceptibility to 0.5% malathion, 0.1% bendiocarb, 0.05% deltamethrin and 0.75% permethrin on 3-5 day old generation one progeny. We also screened for species diversity and knockdown resistance using PCR assay. RESULTS: Anopheles gambiae s.s. is the predominant malaria vector in northern Uganda followed by An. arabiensis. An. gambiae s.s. was susceptible to malathion and bendiocarb with the observed mortality rate of 100% and 98-100% observed respectively while very high resistance was observed with deltamethrin and permethrin. Minimal KDR-eastern variant homozygous forms of 8.3% in An. gambiae s.s. were detected in Oyam district. In conclusion, this study confirms that An. gambiae s.s. females are susceptible to malathion and bendiocarb while high intensity of resistance was observed with deltamethrin and permethrin in the same area. Use of carbamate and organophosphate insecticides bendiocarb and malathion for indoor residual spraying activities in northern Uganda is highly recommended since high levels of pyrethroids resistance (deltamethrin and permethrin) was detected in the area.


Sujet(s)
Anopheles , Insecticides , Paludisme , Pyréthrines , Animaux , Anopheles/génétique , Femelle , Résistance aux insecticides/génétique , Insecticides/pharmacologie , Paludisme/prévention et contrôle , Vecteurs moustiques , Pyréthrines/pharmacologie , Ouganda
2.
Brain Res Bull ; 145: 39-44, 2019 02.
Article de Anglais | MEDLINE | ID: mdl-30458251

RÉSUMÉ

Human onchocerciasis, caused by infection by the filarial nematode Onchocerca volvulus, is a major neglected public health problem that affects millions of people in the endemic regions of sub-Saharan Africa and Latin America. Onchocerciasis is known to be associated with skin and eye disease and more recently, neurological features have been recognized as a major manifestation. Especially the latter poses a severe burden on affected individuals and their families. Although definite studies are awaited, preliminary evidence suggests that neurological disease may include the nodding syndrome, Nakalanga syndrome and epilepsy but to date, the exact pathophysiological mechanisms remain unclear. Currently, the only way to prevent Onchocera volvulus associated disease is through interventions that target the elimination of onchocerciasis through community distribution of ivermectin and larviciding the breeding sites of the Similium or blackfly vector in rivers. In this review, we discuss the epidemiology, potential pathological mechanisms as well as prevention and treatment strategies of onchocerciasis, focusing on the neurological disease.


Sujet(s)
Onchocercose/épidémiologie , Onchocercose/physiopathologie , Afrique/épidémiologie , Afrique subsaharienne/épidémiologie , Animaux , Épilepsie/complications , Humains , Ivermectine/pharmacologie , Onchocerca volvulus/pathogénicité , Onchocercose/thérapie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE